Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AA13 LEFLUNOMIDUM COMPR. FILM. 100 mg

ARAVA 100 mg 100 mg SANOFI-AVENTIS DEUTSCHLAND

GMBH
L04AA13 LEFLUNOMIDUM COMPR. FILM. 10 mg

ARAVA 10 mg 10 mg SANOFI-AVENTIS DEUTSCHLAND

GMBH
L04AA13 LEFLUNOMIDUM COMPR. FILM. 20 mg

ARAVA 20 mg 20 mg SANOFI-AVENTIS DEUTSCHLAND

GMBH

________________________________________________________________________________
______________________________________________________________________________

| 519 |L04AX01| AZATHIOPRINUM* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AX01 AZATHIOPRINUM COMPR. FILM. 50 mg

IMURAN(R) 50 mg THE WELLCOME FOUNDATION

LTD.

________________________________________________________________________________
______________________________________________________________________________

| 520 |M01AB05| DICLOFENACUM | |

|_______|_______|____________________________________________|_________________|
A se administra cu precauţie la pacienţii cu istoric de factori de risc sau afecţiuni gastrointestinale.